Search Results

Containing any of the words

Only of the type

SFDA and Mawani Convene Meeting with Company Representatives to Enhance Supply Chain Resilience Locally and Regionally News

(WU2616) NCMDR Weekly Update Medical Report

Guideline on good pharmacovigilance practices(GVP)Product- or Population-Specific Considerations III: Advanced Therapy Medicinal Products Regulations

The National Nutrition Committee Holds Fourth Meeting of its Third Session News

The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients with Moderate-to-Severe Atopic Dermatitis in Gulf Countries: DERMIND-AD Drug Clinical Trial

A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination with Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer. Drug Clinical Trial

Phase 3 study to evaluate the efficacy and safety of zodasiran in adolescent and adult subjects with homozygous familial hypercholesterolemia (YOSEMITE) Drug Clinical Trial

A Phase 3, Open-label, Randomized, Controlled Trial of Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults with Philadelphia Chromosome Negative B-cell Precursor Acute Lymphoblastic Leukaemia Drug Clinical Trial

A Phase 2/3, Open-Label, Randomized, Controlled, Multicenter Study of KYV-101, an Autologous Fully Human Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, Versus Ongoing Standard-Of-Care Immunosuppressive Therapy in Patients with Generalized Myasthenia Gravis (KYSA-6). Drug Clinical Trial

A Phase 1/2, Global, Open-Label, Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705 Drug Clinical Trial